Literature DB >> 18811883

Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Oren Fruchter1, Mordechai Yigla.   

Abstract

BACKGROUND AND
OBJECTIVE: There is a paucity of survival data regarding the prognosis of elderly patients following acute exacerbations of COPD (AECOPD). We undertook a study to examine long-term mortality rates and to identify clinical and laboratory predictors of these outcomes.
METHODS: A retrospective cohort study was conducted of 786 consecutive elderly (>65 years) patients admitted to general medicine acute-care wards for AECOPD. Factors determining short- and long-term mortality were analysed.
RESULTS: The mean (+/-SD) age of the study population was 75.8 +/- 7.3 years (range 65-100 years). The in-hospital mortality rate for the entire cohort was 7.25%. The risk of mortality at 1, 3 and 5 years was 28%, 47% and 54%, respectively. In univariate analysis age (hazard ratio 1.52; 95% confidence interval: 1.23-1.91), FEV(1) (1.45; 1.73-2.35), active cancer (1.23; 1.64-2.32), current smoking (1.74; 1.35-2.11), ischaemic heart disease (1.58; 1.28-2.02), congestive heart failure (1.55; 1.23-2.26) and maintenance use of oral glucocorticosteroids (1.58; 1.11-2.79) were significantly associated with mortality. In multivariate analysis, only current smoking (1.89; 1.18-1.93), ischaemic heart disease (1.41; 1.07-1.68), PaCO(2) on admission (1.49; 1.03-1.60), hospital readmission (2.23; 1.40-2.18) and FEV(1) (1.41; 1.12-1.54) were independent predictors of mortality.
CONCLUSIONS: This study provides new insights into the predictive factors associated with long-term prognosis in elderly patients admitted for acute exacerbations of COPD, which differ from those previously identified for younger patients.

Entities:  

Mesh:

Year:  2008        PMID: 18811883     DOI: 10.1111/j.1440-1843.2008.01367.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  11 in total

1.  Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study.

Authors:  Timothy L Lash; Martin B Johansen; Steffen Christensen; John A Baron; Kenneth J Rothman; Jens G Hansen; Henrik Toft Sørensen
Journal:  Lung       Date:  2010-12-19       Impact factor: 2.584

2.  Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study.

Authors:  Kristjana Einarsdóttir; David B Preen; Frank M Sanfilippo; Raylene Reeve; Jon D Emery; C D'Arcy J Holman
Journal:  BMC Public Health       Date:  2010-07-01       Impact factor: 3.295

3.  Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Authors:  Cristóbal Esteban; Ady Castro-Acosta; Carlos Jose Alvarez-Martínez; Alberto Capelastegui; José Luis López-Campos; Francisco Pozo-Rodriguez
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

4.  Pulmonary Hypertension and Right Heart Failure in Chronic Kidney Disease: New Challenge for 21st-Century Cardionephrologists.

Authors:  L Di Lullo; F Floccari; R Rivera; V Barbera; A Granata; G Otranto; A Mudoni; M Malaguti; A Santoboni; C Ronco
Journal:  Cardiorenal Med       Date:  2013-07       Impact factor: 2.041

5.  Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization.

Authors:  Gajanan S Gaude; B P Rajesh; Alisha Chaudhury; Jyothi Hattiholi
Journal:  Lung India       Date:  2015 Sep-Oct

6.  Determining prognosis in acute exacerbation of COPD.

Authors:  Yves Flattet; Nicolas Garin; Jacques Serratrice; Arnaud Perrier; Jérome Stirnemann; Sebastian Carballo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-31

7.  Prehospital prognosis is difficult in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Katrine P Lindvig; Anne C Brøchner; Annmarie T Lassen; Søren Mikkelsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-11-02       Impact factor: 2.953

8.  Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.

Authors:  Gui-Yun Jiang; Qun Li; Yun-Xiang Lv
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-20

9.  Evaluation of the effectiveness of manual chest physiotherapy techniques on quality of life at six months post exacerbation of COPD (MATREX): a randomised controlled equivalence trial.

Authors:  Jane L Cross; Frances Elender; Gary Barton; Allan Clark; Lee Shepstone; Annie Blyth; Max O Bachmann; Ian Harvey
Journal:  BMC Pulm Med       Date:  2012-07-02       Impact factor: 3.317

10.  Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.

Authors:  Valerie G Press; David H Au; Jean Bourbeau; Mark T Dransfield; Andrea S Gershon; Jerry A Krishnan; Richard A Mularski; Frank C Sciurba; Jamie Sullivan; Laura C Feemster
Journal:  Ann Am Thorac Soc       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.